Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents.

Research output: Contribution to journalArticlepeer-review

101 Citations (Scopus)
Original languageEnglish
Pages (from-to)3651-3662
Number of pages12
JournalCurrent Pharmaceutical Design
Volume10(29)
Issue number29
Publication statusPublished - 2004

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this